Oswaldo Cruz Foundation-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Oswaldo Cruz Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013305
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oswaldo Cruz Foundation (Oswaldo Cruz) is a provider of research development, vaccines production, drugs, reagents and diagnostic kits. The foundation provides research in experimental models of disease, infectious agent vector biology, information and communication in health, management of science and technology, microbiology, molecular and genetic epidemiology, and others. It offers public laboratories for vaccine production. The foundation offers vaccines such as DTP and haemophilus influenzae type B, yellow fever, haemophilus influenzae type B, meningitis A and C, poliomyelitis and measles, mumps and rubella. Oswaldo Cruz is headquartered in Rio de Janeiro, Brazil.

Oswaldo Cruz Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Oswaldo Cruz Foundation, Medical Devices Deals, 2011 to YTD 2017 9
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sanofi Pasteur Expands R&D Agreement with Walter Reed Army Institute of Research and Bio Manguinhos and Fiocruz 11
Globavir Enters into Co-Development Agreement with Biomanguinhos 12
GenCell Biosystems To Enter Into Agreement With Fiocruz, Institute Of Molecular Biology Of Parana And Immunobiological Technology Institute To Develop Clinical Screening Systems 13
Protalix Enters Into Technology Transfer Agreement With Oswaldo Cruz Foundation For Uplyso 14
Eisai Enters Into R&D Agreement With Oswaldo Cruz Foundation For Malaria And Neglected Tropical Diseases 16
Biomm Enters Into Agreement With Fundacao Oswaldo Cruz To Develop Insulin 17
Licensing Agreements 18
iBio Extends its Licensing Agreement with Bio-Manguinhos 18
iBio Enters Into Licensing Agreement With Bio-Manguinhos 19
Oswaldo Cruz Foundation – Key Competitors 20
Oswaldo Cruz Foundation – Key Employees 21
Oswaldo Cruz Foundation – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 22
Recent Developments 23
Government and Public Interest 23
Jul 27, 2016: IBM Intensifies Fight Against Zika 23
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Key Facts 2
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Oswaldo Cruz Foundation, Deals By Therapy Area, 2011 to YTD 2017 8
Oswaldo Cruz Foundation, Medical Devices Deals, 2011 to YTD 2017 9
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sanofi Pasteur Expands R&D Agreement with Walter Reed Army Institute of Research and Bio Manguinhos and Fiocruz 11
Globavir Enters into Co-Development Agreement with Biomanguinhos 12
GenCell Biosystems To Enter Into Agreement With Fiocruz, Institute Of Molecular Biology Of Parana And Immunobiological Technology Institute To Develop Clinical Screening Systems 13
Protalix Enters Into Technology Transfer Agreement With Oswaldo Cruz Foundation For Uplyso 14
Eisai Enters Into R&D Agreement With Oswaldo Cruz Foundation For Malaria And Neglected Tropical Diseases 16
Biomm Enters Into Agreement With Fundacao Oswaldo Cruz To Develop Insulin 17
iBio Extends its Licensing Agreement with Bio-Manguinhos 18
iBio Enters Into Licensing Agreement With Bio-Manguinhos 19
Oswaldo Cruz Foundation, Key Competitors 20
Oswaldo Cruz Foundation, Key Employees 21
Oswaldo Cruz Foundation, Subsidiaries 22
Oswaldo Cruz Foundation, Joint Venture 22

★海外企業調査レポート[Oswaldo Cruz Foundation-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ineos Group AG:企業の戦略的SWOT分析
    Ineos Group AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Petrochemical Corporation of Singapore (Private) Ltd:企業の戦略的SWOT分析
    Petrochemical Corporation of Singapore (Private) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key comp …
  • Power Mech Projects Ltd (POWERMECH):企業の財務・戦略的SWOT分析
    Power Mech Projects Ltd (POWERMECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Jabil Inc (JBL):企業の財務・戦略的SWOT分析
    Jabil Inc (JBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • PerkinElmer Inc (PKI):企業の製品パイプライン分析
    Summary PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services. The company’s major products include cytogenetics reagents, ELISA Kits, tissue biomarker reagents, atomic spectroscopy instruments, chromatography …
  • Mylan NV (MYL):医療機器:M&Aディール及び事業提携情報
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines, and consumer healthcare products. It offers pharmaceutical products in multiple forms for various disease conditions related to respiratory and allerg …
  • Hochschild Mining plc:企業のM&A・事業提携・投資動向
    Hochschild Mining plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hochschild Mining plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • The Finish Line Inc:企業の戦略・SWOT・財務分析
    The Finish Line Inc - Strategy, SWOT and Corporate Finance Report Summary The Finish Line Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • U.S. Bancorp:企業の戦略・SWOT・財務情報
    U.S. Bancorp - Strategy, SWOT and Corporate Finance Report Summary U.S. Bancorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Wenzel Downhole Tools Ltd:企業の戦略的SWOT分析
    Wenzel Downhole Tools Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • BTB Real Estate Investment Trust:企業の戦略・SWOT・財務分析
    BTB Real Estate Investment Trust - Strategy, SWOT and Corporate Finance Report Summary BTB Real Estate Investment Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Royal Bank of Canada:企業の戦略・SWOT・財務情報
    Royal Bank of Canada - Strategy, SWOT and Corporate Finance Report Summary Royal Bank of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • BP Plc (BP.)-石油・ガス分野:企業M&A・提携分析
    Summary BP p.l.c. (BP) is an integrated oil and gas company. It provides fuel, energy, lubricants and petrochemicals to its customers. Its upstream activities include oil and natural gas exploration, field development and production; and midstream operations include transportation, and marketing and …
  • Toshiba Corp (6502):電力:M&Aディール及び事業提携情報
    Summary Toshiba Corp (Toshiba) is an electronics, electrical equipment and information technology company. The company offers digital consumer products such as LCD TV, Blue-ray disc servers, tablet and Note PC’s; electronic devices and components including solid-state drive NAND flash memory, hard d …
  • Cathay Pacific Airways Limited
    Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report Summary Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Advicenne SA (ADVIC)-製薬・医療分野:企業M&A・提携分析
    Summary Advicenne SA (Advicenne) is a developer of pediatric medicines. The company’s product portfolio includes ADV6209, a liquid formulation of a benzodiazepine for moderate sedation and anesthetic premedication; ADV7103, a formulation in the form of micro-tablets for renal tubulopathies. It offer …
  • High Plains Power Inc:企業の戦略的SWOT分析
    High Plains Power Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Komatsu Ltd (6301):企業の財務・戦略的SWOT分析
    Komatsu Ltd (6301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Kumiai Chemical Industry Co Ltd (4996):企業の財務・戦略的SWOT分析
    Summary Kumiai Chemical Industry Co Ltd (Kumiai Chemical) operates as a chemical company that develops, manufactures and markets agricultural chemicals, fine chemicals, and curing agents. The company's agricultural chemicals include bactericides, herbicides, fungicides, acaricides, microbial pestici …
  • Falck Renewables SpA (FKR)
    Falck Renewables SpA (FKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company

◆H&Iグローバルリサーチ株式会社のお客様(例)◆